September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Updated ASH / ISTH Clinical Guidelines 2024

Hemostasis

Jun 15, 2025, 06:11

Updated ASH / ISTH Clinical Guidelines 2024

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Title: American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

Authors: Paul Monagle, Muayad Azzam, Rachel Bercovitz, Marisol Betensky , Rukhmi Bhat, Tina Biss, Brian Branchford, Leonardo R. Brandão, Anthony K. C. Chan, E. Vincent S. Faustino, Julie Jaffray, Sophie Jones, Hassan Kawtharany, Bryce A. Kerlin, Nicole Kucine, Riten Kumar , Christoph Male , Marie-Claude Pelland-Marcotte, Leslie Raffini, Chittalsinh Raulji, Reem A. Mustafa.

See detailed information in Hemostasis Today.

American Society of Hematology American Thrombosis and Hemostasis Network Anthony K C Chan ASH Fundamentals for Hematology Fellows program Brian Branchford Bryce A. Kerlin Chittalsinh Raulji Christoph Male E. Vincent S. Faustino Hassan Kawtharany Hematology Hemoastasis Today Julie Jaffray Leonardo R. Brandão Leslie Raffini Marie-Claude Pelland-Marcotte Marisol Betensky Muayad Azzam Nicole Kucine Paul Monagle Rachel Bercovitz Reem A. Mustafa Riten Kumar Rukhmi Bhat Sophie Jones Tina Biss updated guidelines venous thromboembolism

'

Targeted Thrombolysis Beyond tPA

'

CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing

'

Managing Thrombotic Risk in Pregnancy

'

Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan

'

10 Posts Not to Miss This Week

NewsFeed

Sep 24, 2026, 14:33
Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
Sep 24, 2026, 14:22
Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
Sep 24, 2026, 13:41
Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
Sep 24, 2026, 12:56
Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
Sep 24, 2026, 12:44
Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
Sep 24, 2026, 12:34
Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
Sep 24, 2026, 12:15
Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
Sep 24, 2026, 11:48
Factor XII Inhibition and the Future of Contact Pathway Targeting
Sep 24, 2026, 08:55
Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Hemostasis Today

Organizations

Updated ASH / ISTH Clinical Guidelines 2024

Clinical Takeaways: Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.

The 2024 iteration refines duration decision-making using newer DOACs and better incorporates bleeding risk and patient preferences.

Stay tuned for full 2024 guidelines expected in Blood Advances or via ASH/ISTH websites.

Clinical Takeaways:
Final authority remains 2023 ASH guidelines until full 2024 publication—but updates add precision, especially in non-surgical VTE and cancer-associated scenarios.